Cedrik Labreche
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Expression of a kinase inactive SLK is embryonic lethal and impairs cell migration in fibroblasts.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: January 15, 2024
CEACAM1 is a direct SOX10 target and inhibits melanoma immune infiltration and stemness.
Journal: iScience
Published: October 09, 2022
Correction to: AKT-mediated phosphorylation of Sox9 induces Sox10 transcription in a murine model of HER2-positive breast cancer.
Journal: Breast cancer research : BCR
Published: May 27, 2021
Periostin gene expression in neu-positive breast cancer cells is regulated by a FGFR signaling cross talk with TGFβ/PI3K/AKT pathways.
Journal: Breast cancer research : BCR
Published: May 07, 2021
AKT-mediated phosphorylation of Sox9 induces Sox10 transcription in a murine model of HER2-positive breast cancer.
Journal: Breast cancer research : BCR
Published: July 30, 2020
Muscle-specific deletion of SLK/Stk2 enhances p38 activity and myogenesis in mdx mice.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: July 29, 2020
Loss of the Ste20-like kinase induces a basal/stem-like phenotype in HER2-positive breast cancers.
Journal: Oncogene
Published: July 29, 2019
Recruitment and activation of SLK at the leading edge of migrating cells requires Src family kinase activity and the LIM-only protein 4.
Journal: Biochimica et biophysica acta
Published: February 04, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026